BIOTIN is a Marie Skłodowska-Curie Action (MSCA)-cofunded program aiming to provide 10 doctoral candidates (DCs) a unique blend of research training skills in the convergence of life sciences, engineering, and computational & data science, and entrepreneurship skills, with the aim of advancing innovation in biomedical research and education.
Successful candidates will be enrolled in a doctoral program offered by one of the 3 implementing partners with the aim of obtaining their doctoral degree. The BIOTIN program will be a unique educational experience immersing DCs in courses and trainings on entrepreneurship at the early stages of their curriculum, on data science and computing, as well as biomedical sciences and engineering courses. In addition to the theoretical courses and trainings, each recruited DC fellow will be required to complete PhD thesis. BIOTIN program offers 20 PhD thesis projects, in the fields of Drug Discovery and Development, Diagnostics, Tissue Engineering & Artificial Organs, which the DCs can choose from at the time of application for the program.
The BIOTIN program offers DCs a rich secondment, short- visit and training program. All DCs will engage in at least one research secondment at an international academic institution, and at least one short-visit or training at an industry partner (in Turkey or in abroad). See our associated partners for academic secondment and industry training opportunities.
This project has received funding from the European Union’s Horizon Europe research and innovation program under the Marie Skłodowska-Curie Grant Agreement No. 101081373. It has also been co-funded by The Scientific and Technological Research Council of Türkiye (TÜBİTAK) and İzmir Institute of Technology (IZTECH).